This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Aileen Ryan
Senior Regulatory Advisor at Prometrika, LLC
Speaker

Profile

Ms. Aileen Ryan, Senior Regulatory Affairs Advisor, has over 40 years of diverse experience in pharmaceutical regulatory affairs, including regulatory strategy, submission preparation (IND/NDA/BLA/MAA), and health authority interactions. Her experience spans submissions in the US, Canada, EU, and Japan. Other leadership roles have included supervision of clinical quality assurance, medical writing, and safety functions.


Prior to joining PROMETRIKA, Ms. Ryan’s leadership roles have included Head of Regulatory Affairs and Compliance at the Ludwig Institute for Cancer Research, Vice President of Regulatory Affairs at Allos Therapeutics, Ophtherion, and Vion Pharmaceuticals, and Head of Global Regulatory Strategy for Oncology at Bayer Pharmaceuticals. Her work has covered drugs, biologics, and devices across a wide range of therapeutic areas. Recent areas of focus have centered on oncology, particularly early phase studies of immunotherapy treatments.


Ms. Ryan received her Bachelor of Science degree in Biochemistry from the University Massachusetts at Amherst and a Master’s of Science in Basic Medical Sciences from New York Medical College.

Agenda Sessions

  • Regulatory CMC Strategies for Early Peptide Development

    2:15pm